← FDA DRUG APPROVALS

FDA ANDA · ANDA075072

VERAPAMIL HYDROCHLORIDE

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA075072
TYPE
ANDA
ORIGINAL APPROVAL
1999-05-25
LATEST ACTION
2002-05-20
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 240MG · TABLET, EXTENDED RELEASE · ORAL
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 120MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2002-05-20Manufacturing (CMC) · Supplement 5AP
2002-05-20Manufacturing (CMC) · Supplement 6AP
2002-03-22Manufacturing (CMC) · Supplement 4AP
2001-08-21Labeling · Supplement 3AP
2001-02-14Labeling · Supplement 2AP
1999-06-24Manufacturing (CMC) · Supplement 1AP
1999-05-25Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →